Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo

References

• Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res 2007; 17:195 - 211; PMID: 17325692
   PubMed Web of Science ®Google Scholar
• Weichert W, Röske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, et al. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res 2008; 14:1669 - 77; http://dx.doi.org/10.1158/1078-0432.CCR-07-0990; PMID: 18347167
   PubMed Web of Science ®Google Scholar
• Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett 2009; 280:168 - 76; http://dx.doi.org/10.1016/j.canlet.2008.10.047; PMID: 19103471
   PubMed Web of Science ®Google Scholar
• Khan O, La Thangue NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol 2012; 90:85 - 94; http://dx.doi.org/10.1038/icb.2011.100; PMID: 22124371
   PubMed Web of Science ®Google Scholar
• Beumer JH, Tawbi H. Role of histone deacetylases and their inhibitors in cancer biology and treatment. Curr Clin Pharmacol 2010; 5:196 - 208; http://dx.doi.org/10.2174/157488410791498770; PMID: 20406169
   PubMedGoogle Scholar
• Ellis L, Hammers H, Pili R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 2009; 280:145 - 53; http://dx.doi.org/10.1016/j.canlet.2008.11.012; PMID: 19111391
   PubMed Web of Science ®Google Scholar
• Srivastava RK, Kurzrock R, Shankar S. MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. Mol Cancer Ther 2010; 9:3254 - 66; http://dx.doi.org/10.1158/1535-7163.MCT-10-0582; PMID: 21041383
   PubMed Web of Science ®Google Scholar
• Martínez-Iglesias O, Ruiz-Llorente L, Sánchez-Martínez R, García L, Zambrano A, Aranda A. Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer. Clin Transl Oncol 2008; 10:395 - 8; http://dx.doi.org/10.1007/s12094-008-0221-x; PMID: 18628067
   PubMed Web of Science ®Google Scholar
• Jazirehi AR. Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy. Anticancer Drugs 2010; 21:805 - 13; http://dx.doi.org/10.1097/CAD.0b013e32833dad91; PMID: 20679890
   PubMed Web of Science ®Google Scholar
• Nishioka C, Ikezoe T, Yang J, Koeffler HP, Yokoyama A. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells. Leukemia 2008; 22:2159 - 68; http://dx.doi.org/10.1038/leu.2008.243; PMID: 18784743
   PubMed Web of Science ®Google Scholar
• Prince HM, Bishton MJ, Harrison SJ. Clinical studies of histone deacetylase inhibitors. Clin Cancer Res 2009; 15:3958 - 69; http://dx.doi.org/10.1158/1078-0432.CCR-08-2785; PMID: 19509172
   PubMed Web of Science ®Google Scholar
• Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 2010; 3:5; http://dx.doi.org/10.1186/1756-8722-3-5; PMID: 20132536
   PubMed Web of Science ®Google Scholar
• Thakur VS, Gupta K, Gupta S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis 2012; 33:377 - 84; http://dx.doi.org/10.1093/carcin/bgr277; PMID: 22114073
   PubMed Web of Science ®Google Scholar
• Vaid M, Prasad R, Singh T, Jones V, Katiyar SK. Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators. Toxicol Appl Pharmacol 2012; 263:122 - 30; http://dx.doi.org/10.1016/j.taap.2012.06.013; PMID: 22749965
   PubMed Web of Science ®Google Scholar
• Nandakumar V, Vaid M, Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011; 32:537 - 44; http://dx.doi.org/10.1093/carcin/bgq285; PMID: 21209038
   PubMed Web of Science ®Google Scholar
• Li TSC. Chinese and related North American herbs: phytopharmacology and therapeutic values. Boca Raton, FL: CRC Press, 2002.
   Google Scholar
• Vaid M, Sharma SD, Katiyar SK. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Carcinogenesis 2010; 31:2004 - 11; http://dx.doi.org/10.1093/carcin/bgq186; PMID: 20823108
   PubMed Web of Science ®Google Scholar
• Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 2003; 278:35501 - 7; http://dx.doi.org/10.1074/jbc.M302967200; PMID: 12816951
   PubMed Web of Science ®Google Scholar
• Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 2005; 106:690 - 7; http://dx.doi.org/10.1182/blood-2004-11-4273; PMID: 15802533
   PubMed Web of Science ®Google Scholar
• Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, et al. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10:3459 - 63; PMID: 15526365
   PubMed Web of Science ®Google Scholar
• Park EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, et al. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 2009; 277:133 - 40; http://dx.doi.org/10.1016/j.canlet.2008.11.029; PMID: 19135778
   PubMed Web of Science ®Google Scholar
• Hahm ER, Arlotti JA, Marynowski SW, Singh SV. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 2008; 14:1248 - 57; http://dx.doi.org/10.1158/1078-0432.CCR-07-1926; PMID: 18281560
   PubMed Web of Science ®Google Scholar
• Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, et al. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 2010; 16:2571 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-10-0333; PMID: 20388852
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer facts and figures. Available: http://www.cancer.org/. Accessed 2011, June 20.
   Google Scholar
• Proctor RN. Tobacco and the global lung cancer epidemic. Nat Rev Cancer 2001; 1:82 - 6; http://dx.doi.org/10.1038/35094091; PMID: 11900255
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10 - 30; http://dx.doi.org/10.3322/canjclin.55.1.10; PMID: 15661684
   PubMed Web of Science ®Google Scholar
• Maziak DE, Markman BR, MacKay JA, Evans WK, Cancer Care Ontario Practice Guidelines Initiative Lung Cancer Disease Site Group. Cancer Care Ontario Practice Guidelines Initiative Lung Cancer Disease Site Group. Photodynamic therapy in non-small cell lung cancer: a systematic review. Ann Thorac Surg 2004; 77:1484 - 91; http://dx.doi.org/10.1016/j.athoracsur.2003.07.017; PMID: 15063303
   PubMed Web of Science ®Google Scholar
• Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000; 355:479 - 85; PMID: 10841143
   PubMed Web of Science ®Google Scholar
• Sharma SD, Meeran SM, Katiyar SK. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors. Mol Cancer Ther 2010; 9:569 - 80; http://dx.doi.org/10.1158/1535-7163.MCT-09-0638; PMID: 20145019
   PubMed Web of Science ®Google Scholar
• Morgan DO. Principles of CDK regulation. Nature 1995; 374:131 - 4; http://dx.doi.org/10.1038/374131a0; PMID: 7877684
   PubMed Web of Science ®Google Scholar
• Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 1999; 287:821 - 8; http://dx.doi.org/10.1006/jmbi.1999.2640; PMID: 10222191
   PubMed Web of Science ®Google Scholar
• Davis CD, Ross SA. Dietary components impact histone modifications and cancer risk. Nutr Rev 2007; 65:88 - 94; http://dx.doi.org/10.1111/j.1753-4887.2007.tb00285.x; PMID: 17345961
   PubMed Web of Science ®Google Scholar
• Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37:391 - 400; http://dx.doi.org/10.1038/ng1531; PMID: 15765097
   PubMed Web of Science ®Google Scholar
• Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435:1262 - 6; http://dx.doi.org/10.1038/nature03672; PMID: 15988529
   PubMed Web of Science ®Google Scholar
• Marsoni S, Damia G, Camboni G. A work in progress: the clinical development of histone deacetylase inhibitors. Epigenetics 2008; 3:164 - 71; http://dx.doi.org/10.4161/epi.3.3.6253; PMID: 18487953
   PubMed Web of Science ®Google Scholar
• Kelly WK, Marks PA. Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol 2005; 2:150 - 7; http://dx.doi.org/10.1038/ncponc0106; PMID: 16264908
   PubMedGoogle Scholar
• Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 2005; 45:495 - 528; http://dx.doi.org/10.1146/annurev.pharmtox.45.120403.095825; PMID: 15822187
   PubMed Web of Science ®Google Scholar
• Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 2000; 60:5165 - 70; PMID: 11016644
   PubMed Web of Science ®Google Scholar
• Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990; 265:17174 - 9; PMID: 2211619
   PubMed Web of Science ®Google Scholar
• Graña X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11:211 - 9; PMID: 7624138
   PubMed Web of Science ®Google Scholar
• Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000; 33:261 - 74; http://dx.doi.org/10.1046/j.1365-2184.2000.00191.x; PMID: 11063129
   PubMed Web of Science ®Google Scholar
• Kastan MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14:3 - 15; http://dx.doi.org/10.1007/BF00690207; PMID: 7606818
   PubMed Web of Science ®Google Scholar
• Singh T, Sharma SD, Katiyar SK. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo. PLoS One 2011; 6:e27444; http://dx.doi.org/10.1371/journal.pone.0027444; PMID: 22087318
   PubMed Web of Science ®Google Scholar
• Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006; 27:2018 - 27; http://dx.doi.org/10.1093/carcin/bgl043; PMID: 16621886
   PubMed Web of Science ®Google Scholar
• Prasad R, Katiyar SK. Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules. PLoS One 2012; 7:e46404; http://dx.doi.org/10.1371/journal.pone.0046404; PMID: 23050025
   PubMed Web of Science ®Google Scholar